In a recent study of 112 adult and pediatric osteosarcoma cases, these mutations were detected in 7%, whereas in an additional 87 osteosarcomas, IGF-IR amplification was observed in 14% of tumors [75]. This evidence concerns the gene IGF1R and osteosarcoma.